Ado-trastuzumab emtansine (T-DM1) in patients (pts) with HER2 amplified (amp) tumors excluding breast and gastric/gastro-esophageal junction (GEJ) adenocarcinomas: Results from the National Cancer Institute (NCI) Molecular Analysis for Therapy Choice (MATCH) trial.

Author:

Jhaveri Komal L.1,Makker Vicky2,Wang Xin Victoria3,Chen Alice P.4,Flaherty Keith5,Conley Barbara A.6,O'Dwyer Peter J.7,Williams Paul M.8,Hamilton Stanley R.9,Harris Lyndsay10,McShane Lisa11,Rubinstein Lawrence11,Gray Robert James12,Li Shuli12,Mitchell Edith P.13,Patton David14,Moscow Jeffrey15,Zwiebel James A.16,Arteaga Carlos L.17,Luoh Shiuh-Wen18

Affiliation:

1. New York University Cancer Institute, New York, NY;

2. Memorial Sloan Kettering Cancer Center, New York, NY;

3. Dana-Farber Cancer Institute/ Harvard Medical School, Boston, MA;

4. Early Clinical Trials Development Program, DCTD, National Cancer Institute at the National Institutes of Health, Bethesda, MD;

5. Massachusetts General Hospital, Boston, MA;

6. National Cancer Institute, Rockville, MD;

7. University of Pennsylvania Abramson Cancer Center, Philadelphia, PA;

8. Frederick National Laboratory for Cancer Research, Frederick, MD;

9. The University of Texas MD Anderson Cancer Center, Houston, TX;

10. Cancer Diagnosis Program, National Cancer Institute, Rockville, MD;

11. National Cancer Institute, Bethesda, MD;

12. Dana-Farber Cancer Institute, Boston, MA;

13. Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA;

14. National Cancer Institute/Center for Biomedical Informatics & Information Technology, Rockville, MD;

15. J457 Kentucky Clinic, Lexington, KY;

16. Cancer Therapy Evaluation Program, Bethesda, MD;

17. Vanderbilt University Ingram Cancer Center, Nashville, TN;

18. Oregon Health Sci Univ, Lake Oswego, OR;

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3